Skip Navigation

Advertise|Press|Contact|FAQ|About Us


Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, CA

Clinical Trial Details


Research Study Summary

You may be eligible to join the EMERGE STUDY if you

  • Are between 18 and 75 years old
  • Have been taking a stable dose of pioglitazone ≥ 30 mg/day and metformin ≥ 1,500 mg/day (or the maximum tolerated dose or maximum dose specified on the label) for at least 12 months
  • Have had no treatment with insulin for longer than 1 week during the past 6 months
  • Have weighed about the same for at least 12 weeks
  • Agree to maintain you current diet and exercise habits throughout your participation in the study

If you decide to join the study, you will be asked to:

  • Take your study medication (by injection) once a week for up to 52 weeks
  • Atted up to 11 study visits during a 1-year period and participate in a follow-up telephone visit
  • Undergo study-related procedures, including:
    • Blood draws and urine samples
    • Physical examinations (including weight and waist/hip circumference measurement
    • Vital signs (blood pressure, heart rate)
    • ECG testing
    • Glucose testing
  • Monitor your glucose levels at home
  • Maintain a study diary

To find out more and to see if you qualify, please call:

To Learn more

Both Male and Female


18 to 75 Years

Overall Status


Facility Type



Diablo Clinical Research
2255 Ygnacio Valley Rd., Suite M
Walnut Creek, CA 94598
Phone: 925-930-7267
Fax: 925-930-7392

View Map

Research Center Information: Diablo Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Zip/Postal Code:
Please leave this field empty.

CW ID: 156058

Date Last Changed: July 24, 2013

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.